Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors
Cancer Survivor, Stage 0 Breast Cancer, Stage IA Breast Cancer
About this trial
This is an interventional supportive care trial for Cancer Survivor
Eligibility Criteria
Inclusion Criteria:
- Diagnosed with breast cancer stages 0-III within 6 months after completion of all planned surgery, radiation and or chemotherapy treatments
- Concurrent endocrine therapy permissible
- Ability to understand and the willingness to sign a written informed consent
- Willingness to participate in CR program
Exclusion Criteria:
- Existing CVD
- Existing diabetes
- Contraindications to exercise
- Metastatic breast cancer
- Other concurrent malignancies except skin cancer
- Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, or psychiatric illness/social situation that would limit compliance with study requirements
- Pregnant or nursing women
- Unable to give informed consent
- Any contraindication to cardiac stress testing
- Travel distance greater than 50 miles
Sites / Locations
- Ohio State University Comprehensive Cancer Center
Arms of the Study
Arm 1
Experimental
Supportive care (CR program)
Patients participate in a CR program consisting of 1-hour CR intervention sessions, based on a personalized exercise prescription, 3 times per week for 14 weeks (a total of 36 sessions). Components of the exercise prescription includes intensity, mode, duration, and frequency. Intensity of exercise is guided by the results of a graded exercise stress test, RPE, heart rate, and symptoms, such as chest pain/angina or shortness of breath. If exercise is well-tolerated during CR sessions, patients are encouraged to supplement their exercise program at home, increasing their exercise frequency to up to 5 times per week. Patients may attend weekly educational sessions offered by the Phase 2 CR program which covers topics such as stress management, smoking cessation, nutrition, and weight loss.